Search Results - "SHIN, Daniel"

Association of Racial/Ethnic and Gender Concordance Between Patients and Physicians With Patient Experience Ratings by Takeshita, Junko, Wang, Shiyu, Loren, Alison W, Mitra, Nandita, Shults, Justine, Shin, Daniel B, Sawinski, Deirdre L

“…The Press Ganey Outpatient Medical Practice Survey is used to measure the patient experience. An understanding of the patient- and physician-related…”
Get full text

Multiple functional neurosteroid binding sites on GABAA receptors by Chen, Zi-Wei, Bracamontes, John R, Budelier, Melissa M, Germann, Allison L, Shin, Daniel J, Kathiresan, Krishnan, Qian, Ming-Xing, Manion, Brad, Cheng, Wayland W L, Reichert, David E, Akk, Gustav, Covey, Douglas F, Evers, Alex S

“…Neurosteroids are endogenous modulators of neuronal excitability and nervous system development and are being developed as anesthetic agents and treatments for…”
Get full text

Risk of Serious Infection, Opportunistic Infection, and Herpes Zoster among Patients with Psoriasis in the United Kingdom by Takeshita, Junko, Shin, Daniel B., Ogdie, Alexis, Gelfand, Joel M.

“…The risk of infection among patients with psoriasis of varying severity in a broadly representative population remains poorly understood. Using The Health…”
Get full text

Mental health impairment among children with atopic dermatitis: A United States population-based cross-sectional study of the 2013-2017 National Health Interview Survey by Wan, Joy, Takeshita, Junko, Shin, Daniel B., Gelfand, Joel M.

“…Atopic dermatitis (AD) is associated with mental health disorders, but its impact on global mental health symptoms is less clear. To determine the association…”
Get full text

The evolution of checkpoint blockade as a cancer therapy: what's here, what's next? by Shin, Daniel Sanghoon, Ribas, Antoni

“…Highlights • First FDA approvals for anti-PD-1 antibodies for patients with metastatic melanoma. • Promising response from ongoing clinical trials with several…”
Get full text

Risk of Incident Liver Disease in Patients with Psoriasis, Psoriatic Arthritis, and Rheumatoid Arthritis: A Population-Based Study by Ogdie, Alexis, Grewal, Sungat K., Noe, Megan H., Shin, Daniel B., Takeshita, Junko, Chiesa Fuxench, Zelma C., Carr, Rotonya M., Gelfand, Joel M.

“…Relatively little is known about the risk for incident liver disease in psoriasis (PsO), psoriatic arthritis (PsA), and rheumatoid arthritis (RA). We performed…”
Get full text

Body surface area affected by psoriasis and the risk for psoriatic arthritis: a prospective population-based cohort study by Ogdie, Alexis, Shin, Daniel B, Love, Thorvardur Jon, Gelfand, Joel M

“…Abstract Objective Increasing psoriasis severity has been associated with comorbidities including cardiovascular disease. The objective of this study was to…”
Get full text

The risk of respiratory tract infections and symptoms in psoriasis patients treated with interleukin 17 pathway–inhibiting biologics: A meta-estimate of pivotal trials relevant to decision making during the COVID-19 pandemic by Wan, Marilyn T., Shin, Daniel B., Winthrop, Kevin L., Gelfand, Joel M.

Get full text

Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma by Zaretsky, Jesse M, Garcia-Diaz, Angel, Shin, Daniel S, Escuin-Ordinas, Helena, Hugo, Willy, Hu-Lieskovan, Siwen, Torrejon, Davis Y, Abril-Rodriguez, Gabriel, Sandoval, Salemiz, Barthly, Lucas, Saco, Justin, Homet Moreno, Blanca, Mezzadra, Riccardo, Chmielowski, Bartosz, Ruchalski, Kathleen, Shintaku, I. Peter, Sanchez, Phillip J, Puig-Saus, Cristina, Cherry, Grace, Seja, Elizabeth, Kong, Xiangju, Pang, Jia, Berent-Maoz, Beata, Comin-Anduix, Begoña, Graeber, Thomas G, Tumeh, Paul C, Schumacher, Ton N.M, Lo, Roger S, Ribas, Antoni

“…Whole-exome sequencing was performed on four patients' tumors before exposure to pembrolizumab and after disease progression following a response to treatment…”
Get full text

Racial and ethnic differences in health care utilization for childhood eczema: An analysis of the 2001-2013 Medical Expenditure Panel Surveys by Fischer, Alexander H., Shin, Daniel B., Margolis, David J., Takeshita, Junko

“…Eczema is a common chronic inflammatory disease of the skin. Studies suggest differences in disease prevalence and severity by race/ethnicity. Our knowledge of…”
Get full text

The clinical utility of laboratory monitoring during isotretinoin therapy for acne and changes to monitoring practices over time by Barbieri, John S., Shin, Daniel B., Wang, Shiyu, Margolis, David J., Takeshita, Junko

“…As a result of concerns about hypertriglyceridemia, liver enzyme abnormalities, and leukopenia during isotretinoin therapy for acne, patients are often…”
Get full text

Risk of liver disease in patients with psoriasis, psoriatic arthritis, and rheumatoid arthritis receiving methotrexate: A population-based study by Gelfand, Joel M., Wan, Joy, Zhang, He, Shin, Daniel B., Ogdie, Alexis, Syed, Maha N., Egeberg, Alexander

“…Patients with psoriatic disease may be more susceptible to methotrexate hepatotoxicity than those with rheumatoid arthritis (RA); however, direct evidence…”
Get full text

Psoriasis and the risk of diabetes: A prospective population-based cohort study by Wan, Marilyn T., Shin, Daniel B., Hubbard, Rebecca A., Noe, Megan H., Mehta, Nehal N., Gelfand, Joel M.

“…Data evaluating the impact of objectively measured psoriasis severity on type 2 diabetes mellitus (T2DM) risk are lacking. To determine the risk for T2DM in…”
Get full text

A Phase IV, Randomized, Double-Blind, Placebo-Controlled Crossover Study of the Effects of Ustekinumab on Vascular Inflammation in Psoriasis (the VIP-U Trial) by Gelfand, Joel M., Shin, Daniel B., Alavi, Abass, Torigian, Drew A., Werner, Tom, Papadopoulos, Maryte, Takeshita, Junko, Noe, Megan H., Dey, Amit K., Playford, Martin P., Mehta, Nehal N.

“…Psoriasis is a T helper type 17 autoimmune disease associated with an increased risk cardiovascular events and mortality. Ustekinumab, an antibody to p40,…”
Get full text

Attributable Risk Estimate of Severe Psoriasis on Major Cardiovascular Events by Mehta, Nehal N., MD, MSCE, FAHA, Yu, YiDing, BA, Pinnelas, Rebecca, BS, Krishnamoorthy, Parasuram, MD, Shin, Daniel B., BA, Troxel, Andrea B., ScD, Gelfand, Joel M., MD, MSCE

“…Abstract Background Recent studies suggest that psoriasis, particularly if severe, may be a risk factor for major adverse cardiac events, such as myocardial…”
Get full text

Association of Race/Ethnicity and Sex With Differences in Health Care Use and Treatment for Acne by Barbieri, John S, Shin, Daniel B, Wang, Shiyu, Margolis, David J, Takeshita, Junko

“…Our understanding of potential racial/ethnic, sex, and other differences in health care use and treatment for acne is limited. To identify potential…”
Get more information

The Risk of Cancer in Patients With Psoriasis: A Population-Based Cohort Study in the Health Improvement Network by Chiesa Fuxench, Zelma C, Shin, Daniel B, Ogdie Beatty, Alexis, Gelfand, Joel M

“…The risk of cancer in patients with psoriasis remains a cause of special concern due to the chronic inflammatory nature of the disease, the use of…”
Get more information

Risk of venous thromboembolism in patients with psoriatic arthritis, psoriasis and rheumatoid arthritis: a general population-based cohort study by Ogdie, Alexis, Kay McGill, Neilia, Shin, Daniel B, Takeshita, Junko, Jon Love, Thorvardur, Noe, Megan H, Chiesa Fuxench, Zelma C, Choi, Hyon K, Mehta, Nehal N, Gelfand, Joel M

“…Abstract Aims To determine the risk of venous thromboembolism (VTE) defined as the combined endpoint of deep venous thrombosis (DVT) and pulmonary embolism…”
Get full text

Psoriasis severity and the prevalence of major medical comorbidity: a population-based study by Yeung, Howa, Takeshita, Junko, Mehta, Nehal N, Kimmel, Stephen E, Ogdie, Alexis, Margolis, David J, Shin, Daniel B, Attor, Rosemary, Troxel, Andrea B, Gelfand, Joel M

“…Despite the growing literature on comorbidity risks in psoriasis, there remains a critical knowledge gap on the degree to which objectively measured psoriasis…”
Get more information

A Randomized Placebo-Controlled Trial of Secukinumab on Aortic Vascular Inflammation in Moderate-to-Severe Plaque Psoriasis (VIP-S) by Gelfand, Joel M., Shin, Daniel B., Duffin, Kristina Callis, Armstrong, April W., Blauvelt, Andrew, Tyring, Stephen K., Menter, Alan, Gottlieb, Scott, Lockshin, Benjamin N., Simpson, Eric L., Kianifard, Farid, Sarkar, Rajendra Prasad, Muscianisi, Elisa, Steadman, Jennifer, Ahlman, Mark A., Playford, Martin P., Joshi, Aditya A., Dey, Amit K., Werner, Thomas J., Alavi, Abass, Mehta, Nehal N.

“…Psoriasis, a chronic immune-mediated disease, is associated with an increased risk of cardiovascular events and mortality. Secukinumab selectively neutralizes…”
Get full text